Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Black Garlic is a health-focused biotechnology company that specializes in the development and commercialization of fermented garlic-based therapeutic products. The company leverages a proprietary fermentation process to enhance the concentration of bioactive compounds, such as S-allyl cysteine, which are known for their potent antioxidant and cardioprotective properties. Their product portfolio is primarily directed toward managing cardiovascular health, metabolic disorders, and supporting immune function through natural, science-backed formulations. By bridging the gap between traditional nutraceuticals and clinical-grade supplements, Black Garlic aims to provide effective, non-invasive options for long-term wellness. The company operates within the intersection of food science and biotechnology, focusing on high-quality manufacturing and evidence-based health outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Black Garlic.